NCT00000944View on ClinicalTrials.gov

A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2003

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

Indinavir sulfate

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (4)

10461

Jacobi Med. Ctr., The Bronx

94143

UCSF Pediatric AIDS CRS, San Francisco

02115

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston

Unknown

Montefiore Med. Ctr. - AECOM, The Bronx

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH